Search Close Search
Search Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • UMass Chan to lead perinatal mental health equity study with $21 million PCORI grant

    UMass Chan to lead perinatal mental health equity study with $21 million PCORI grant

    A UMass Chan research team has secured a $21 million award to conduct maternal mental health equity research.

    Read more
  • Tech-based tools for suicide prevention in emergency department offer promise, pilot study finds

    Tech-based tools for suicide prevention in emergency department offer promise, pilot study finds

    A pilot study of technology-based interventions for emergency department patients at risk of suicide found patients rated the interventions highly, leading to further studies on clinical efficacy and potential for sustainable use.

    Read more
  • March of Dimes grant supports UMass Chan study on influence of racism in perinatal care

    March of Dimes grant supports UMass Chan study on influence of racism in perinatal care

    The $200,000 award from The March of Dimes Foundation will help support and expand a clinical trial led by Margaret Parker, MD, MPH, studying the effect of support for low-income mothers of preterm infants on parental caregiving in the NICU.

    Read more
  • UMass Chan Medical School joins ARPA-H Investor Catalyst Hub and Spoke Consortium

    UMass Chan Medical School joins ARPA-H Investor Catalyst Hub and Spoke Consortium

    UMass Chan Medical School joins ARPA-H Investor Catalyst Hub and Spoke Consortium

    Read more
  • In new study, UMass Chan scientists induce toxicity to kill cancer cells

    In new study, UMass Chan scientists induce toxicity to kill cancer cells

    Dohoon Kim, PhD, and colleagues have shown that blocking a specific detoxifying enzyme in lung cancer cells leads to cell death, making it a viable target for drug development.

    Read more
  • Infectious disease expert Laura Gibson, MD’94, honored as WBJ champion of health care

    Infectious disease expert Laura Gibson, MD’94, honored as WBJ champion of health care

    Dr. Gibson’s leadership in CMV research and in advocacy for newborn CMV screening highlighted in inaugural Central Mass Champions of Health Care Award.

    Read more